Blood Safety Product Overview Technical Data Sheets Implementation and Use
 

 

NEWS AND EVENTS: CERUS ISBT SYMPOSIUM

Cerus Symposium: ISBT 2007 (Madrid, Spain - June 26, 2007)

A Single Pathogen Inactivation System for Two Blood Components: INTERCEPT Blood System for Platelets and Plasma

The symposium, “A Single Pathogen Inactivation System for Two Blood Components: INTERCEPT Blood System for Platelets and Plasma” was held as part of the XVIIth International ISBT Congress.

The INTERCEPT Blood System has now been in routine use for several years in Europe, and with our recent CE mark for plasma
becomes the only system available for treating both platelets and plasma. This symposium featured the experiences of Dr. Henschler, Dr. Castro and Prof. Cazenave as producers of INTERCEPT-treated
blood components.

Cerus Symposium: ISBT 2007 Programme and Webcast Videos
(NOTE: each video will open a new browser window.)
Click to View
Windows Media Player)
Presentation/Title
Click to View Video
Welcome and introduction
Dr. James P. AuBuchon (see bio below)
Click to View Video
Implementation in a High Volume Center: in vitro Characteristics of INTERCEPT Plasma
Dr. Reinhard Henschler (see bio below)
Click to View Video
Two Pathogen Inactivated Blood Products from One Donation – Treatment of Platelets and Concurrent Plasma
Dr. Emma Castro Izaguirre (see bio below)
Click to View Video
Synergy of INTERCEPT Platelets and Plasma in Routine Use
Prof. Jean-Pierre Cazenave (see bio below)
Click to View Video
Wrap-up; Q&A
Dr. James P. AuBuchon (see bio below)
Symposium Book Download (PDF, 2.3 MB)
(download now)

The Presenters

Dr. James P. AuBuchon
(Symposium Chair)
Professor & Chair of Pathology
Dartmouth-Hitchcock Medical Center, USA

Dr. AuBuchon attended the University of Michigan for undergraduate work in cellular biology and then for medical school before entering the fi eld of pathology. He completed an anatomic and clinical pathology residency at the University of Wisconsin and was a Senior Staff Fellow in the Department of Transfusion Medicine at the National Institutes of Health. Following his fellowship, Dr. AuBuchon served as
the director of several regional blood centers and the national headquarters of the American Red Cross for 6 years.

Dr. AuBuchon came to Dartmouth-Hitchcock Medical Center as the Medical Director of the Blood Bank and Transfusion Service in 1990. He has pursued several lines of research, continuing his work on component storage system improvement and extending his interest in practical improvements in blood safety through defining the
cost-effectiveness of a variety of proposed interventions.

Dr. AuBuchon has served as the Pathology Residency Program Director for fourteen years and as chair of the Department of Pathology for six years. He served as a member of the Advisory Committee on Blood Safety and Availability of the U.S. Department of Health and Human Services (1997-2000). He has served the American Association of Blood Banks as chair of the Scientific Section Coordinating Committee (1998-2002) and a district director (2003 – present) on the Board of Directors. He chairs the Transfusion Medicine Resource Committee of the College of American Pathologists. He chaired the Biomedical Excellence for Safer Transfusion Collaborative fom 2002 to 2006. He was elected a Fellow of the Royal College of Physicians of Edinburgh in 1999.

Dr. Reinhard Henschler
Head of Production Department
Institute of Transfusion Medicine and Immune Hematology, German
Red Cross Blood Donor Center, University of Frankfurt, Germany

Dr. Henschler is Head of Department of Production of Institute for Transfusion Medicine and Immune Hematology, German Red Cross
Blood Donation Service, University Frankfurt, Frankfurt, Germany since 1999. He studied Medicine in the Medical School of Würzburg University and Mainz University, Germany.

Dr. Henschler has extensive experience in experimental haematology, internal medicine and laboratory medicine.

He was Head of stem cell laboratory at Freiburg University Medical Center before joining the German Red Cross in Frankfurt in 1999.
Dr. Henschler has published over 40 papers in scientific journals.

Dr. Emma Castro Izaguirre
Medical Director & CEO
Spanish Red Cross Blood Center of Madrid, Spain

Dr. Castro studied medicine at the La Laguna University, Spain and obtained the degree of Doctor of Medicine in 1981. She became
a Medical Specialist in Hematology and Hemotherapy at Nuestra Señora de Aranzazu Hospital, San Sebastian, Spain from 1982-
1985. Dr. Castro was awarded the Medical Licenses in Las Palmas de Gran Canaria 3282 (1986) and Madrid 6828 (1995).

Dr. Castro was a medical Resident at the Haematology and Blood Bank Department; Nuestra Señora de Aranzazu Hospital, San
Sebastian, Spain from 1981-1986. She was an attending physician at the Haematology Department and the Blood Bank Director; Nuestra Señora del Pino Hospital, Las Palmas de Gran Canaria, Spain from 1986-1995.

Dr. Castro became the Medical Director of the Spanish Red Cross Blood Center of Madrid (Centro de Transfusión de Cruz Roja Española), Spain in 1995 and has held the position of CEO since 1996.

Dr. Castro has extensive experience in blood banking and transfusion medicine and has published extensively in the field of transfusion
safety.

Prof. Jean-Pierre Cazenave
Director EFS Alsace
Etablissement Français du Sang, France

Jean-Pierre Cazenave was born in L’Aigle, France, on May 6th 1943.
He studied medicine at the School of Medicine of Caen, Normandy, France. He was a Resident in hematology at Strasbourg University Hospital and obtained is MD degree in 1970 at the University Louis Pasteur of Strasbourg.

He moved to Canada where he lived for 8 years. He joined the research group of Professor J.F. Mustard at Mac Master University,
Hamilton, Ontario, where he worked on platelet physiology and pharmacology. He obtained a PhD degree and was appointed
Assistant Professor of Pathology. He returned to Strasbourg, France in 1978 at the Blood Transfusion Center. He created an INSERM
research unit in 1986 devoted to the Biology and Pharmacology of Hemostasis and Thrombosis. Since 1987, he has been the Director of the Blood Transfusion Center in Strasbourg.

He has more recently devoted his research to experimental models of platelet transfusion and to clinical studies of pathogen inactivation of
blood components.

He is Professor of Hematology and Transfusion at University Louis Pasteur, Faculty of Medicine of Strasbourg, member of several international societies and author of 500 publications.

He has been elected as corresponding member (3rd Division, Biological Sciences) of the Académie Nationale de Médecine. Paris,
February 22, 2005.


 
Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.

The INTERCEPT Blood System has received approval for CE Marking for use with platelets and plasma.